NMN for Athletes: Does It Improve Endurance and VO₂ Max?
NMN changed threshold measures in one runners trial without a VO₂ max benefit. A 2026 muscle-biopsy trial adds caution about recovery claims.
Updated
6 min read · 8 sources
On this page
Nicotinamide mononucleotide (NMN) is marketed to athletes as an endurance booster — a supplement that raises NAD+, fuels the mitochondria that power aerobic work, and lifts your aerobic ceiling. Unlike most NMN performance claims, this one isn't pure hand-waving: there is a real, randomized, placebo-controlled human trial behind it. But it's one trial, in a specific population, with important limits — and the rest of the NMN-and-exercise literature is more sobering than the marketing lets on. The runners study needs to be read alongside newer muscle research: reduced inflammatory markers do not necessarily mean better recovery or training adaptation.
The mechanism: why NMN should help endurance
Featured partner
CoreAge Rx
From $93/mo
Check availabilityRead our reviewAffiliate link. We may earn a commission at no extra cost to you.
Affiliate partner
System Labs
Compounded NAD+ & longevity telehealth
See System LabsThe rationale is legitimate. NAD+ is the central electron carrier in the reactions that turn food into ATP, and it powers the mitochondria that endurance performance depends on. NMN is an oral NAD+ precursor that reliably raises blood NAD+ in a dose-dependent way in humans 1, and a pharmaceutical-grade NMN cleanly increased circulating NAD+ and its metabolome 2. NAD+ also tends to fall with age and metabolic stress, and it sits upstream of the sirtuin and PGC-1α signaling that drives mitochondrial biogenesis — exactly the adaptations endurance training is trying to provoke. So on paper, "raise NAD+ → better aerobic metabolism → more endurance" is a coherent hypothesis 6.
The catch — and it's the same catch that haunts the entire NAD+ field — is that raising the NAD+ biomarker has repeatedly failed to translate into improved muscle function. The clearest example: when nicotinamide riboside (NR, NMN's sister precursor) augmented the aged human muscle NAD+ metabolome, it did not improve bioenergetics or physical performance 5. The fuel gauge moved; the engine output didn't. That's the backdrop against which the one positive NMN trial has to be read.
Strength of evidence
- NMN raises blood NAD+ (dose-dependent)Strong evidence
Replicated in randomized human trials.
- NMN → aerobic capacity in amateur runnersModerate evidence
One RCT, 48 runners, 6 weeks, dose-dependent at ~600–1200 mg/day.
- NMN / NR → muscle strength or massWeak evidence
2025 meta-analysis found no reliable improvement.
- NMN → VO₂ max in elite athletes / general populationNone evidence
Untested beyond the single amateur-runner trial.
The endurance trial: 48 amateur runners
The headline evidence is a 2021 randomized, double-blind trial published in the Journal of the International Society of Sports Nutrition. Researchers gave 48 recreationally trained amateur runners NMN or placebo for six weeks across several daily doses — a low dose, a middle dose, and a high dose, roughly spanning **300 to 1,200 mg/day** — while all groups followed the same exercise training 3.
The result that made headlines: the NMN groups showed greater improvement in aerobic capacity during exercise than placebo, and the effect was dose-dependent — the middle and higher doses (around 600 and 1,200 mg/day) drove the benefit, while the lowest dose did not clearly separate from placebo 3. The authors attributed the gain to enhanced oxygen utilization by skeletal muscle rather than to changes in the heart or lungs.
That's a genuine, peer-reviewed, placebo-controlled positive result — which is more than most performance supplements can claim. It's the reason "NMN for endurance" isn't simply a myth. But the same study is also the reason you should keep your expectations measured.
Why one study can't carry the claim
Read carefully, the runners trial supports a narrow statement — NMN may modestly improve a measure of aerobic capacity in amateur runners over six weeks — not the broad "NMN boosts your VO₂ max" sold on supplement labels. Several limits matter:
- It's a single study. No independent group has replicated it. In nutrition science, unreplicated single trials frequently shrink or vanish on repetition, and a lone positive result is a starting point, not a settled fact.
- The population was specific. These were amateur, recreationally trained runners — not elite athletes, and not sedentary beginners. Whether the effect generalizes up to trained competitors or out to the general gym-goer is untested.
- The study did not show a VO₂ max benefit. Improvements were in submaximal ventilatory-threshold measures. Maximal oxygen uptake and those threshold measures answer different questions; the trial did not demonstrate faster race times or better competitive outcomes.
- Six weeks is short. Endurance adaptations and any supplement's real-world value play out over months and seasons, not six weeks.
The runners RCT at a glance
| Feature | What the trial actually was |
|---|---|
| Design | Randomized, double-blind, placebo-controlled |
| Who | 48 amateur, recreationally trained runners |
| How long | 6 weeks, all groups training |
| Doses | ~300–1200 mg/day (low / middle / high) |
| Main result | Submaximal ventilatory-threshold improvements, especially at 600 and 1200 mg; no VO₂ max benefit |
| Biggest caveat | Single, unreplicated study in one population over 6 weeks |
What the rest of the NMN/NAD+ exercise literature shows
Step beyond the runners study and the picture cools considerably. A 2025 systematic review and meta-analysis of NMN and NR specifically on skeletal muscle mass and function found that, pooled across trials, these precursors did not produce reliable improvements in muscle strength or mass — reinforcing that raising NAD+ is not a dependable route to better muscle output 4. A separate placebo-controlled trial of NMN in older adults with diabetes and impaired physical performance reported only limited functional effects 7. And the broader review of NAD+ therapeutics and exercise adaptation concludes the human performance data are early and inconsistent, with mechanism running well ahead of proven benefit 6.
So the honest synthesis is a split-screen: one positive aerobic-capacity trial in runners on one side, and a meta-analysis plus a null NR muscle study plus a cautious review on the other. That's not "NMN doesn't work" — it's "the strongest claim the evidence currently supports is a single, unreplicated, modest, population-specific endurance signal."
The 2026 recovery study: lower inflammation was not a clear win
A randomized crossover experiment published online in February 2026 tested NMN for seven days in 11 young, untrained men before blood-flow-restriction resistance exercise. Muscle biopsies showed reduced expression of some inflammatory signals, but also delayed clearance of infiltrating cells and a suppressed post-exercise increase in mitochondrial content 8.
This is a small mechanistic experiment, not a race-performance or long-term strength trial. It does not establish that NMN harms every training program. It does challenge the assumption that suppressing exercise inflammation automatically improves muscle recovery: inflammation and repair are connected processes. The paper's December 2026 issue date should not be confused with its February online publication.
There is no validated NMN recovery protocol based on these results. Neither the biopsy findings nor the runners study establishes the best timing before or after a workout. For broader uncertainty and medication considerations, see NMN side effects and NMN drug interactions.
Practical reality for athletes
If you're an athlete weighing NMN, a few honest takeaways:
- The specific runners signal remains one small study, so treat any purchase as an experiment with uncertain odds, not a proven edge. For dosing context, the trial used roughly 600–1,200 mg/day; our NAD+ dosage guide walks through how those numbers map to common products.
- NMN is not a stimulant and won't give you an acute pre-workout lift — any plausible benefit is a slow, adaptation-level effect, which is exactly why people overestimate it. We unpack the recurring "does NAD+ boost energy" question and its trial-by-trial reality in does NAD+ actually boost energy.
- The fundamentals still dominate. Structured training, adequate protein, sleep, and iron status move endurance far more reliably than any NAD+ precursor, and none of the NMN data displaces that.
- If you do try it, product quality matters more than the thin efficacy gap between brands — see how the options compare on third-party purity and dose transparency in the best NMN supplements, rated by evidence.
Bottom line
NMN for endurance is the rare NAD+ athletic claim with an actual randomized trial behind it: 48 amateur runners, six weeks, a dose-dependent improvement in aerobic capacity at roughly 600–1,200 mg/day 3. That's real and worth knowing. But it's a single, unreplicated study in a specific population, and the surrounding literature — a meta-analysis finding no reliable muscle benefit 4, a null NR performance result 5, and a cautious exercise-adaptation review 6 — keeps the verdict modest. The 2026 biopsy study adds a separate caution: lower inflammatory signaling is not proof of better repair 8. Neither study establishes a training prescription. For the full evidence picture on what raising NAD+ can and can't do, start with our NAD+ therapy evidence pillar, and see where the products land on our NAD+ rankings hub.
Frequently asked questions
Does NMN actually improve endurance?
One randomized, placebo-controlled trial in 48 amateur runners found a dose-dependent improvement in aerobic capacity over six weeks at roughly 600–1200 mg/day. That's a genuine positive result, but it's a single unreplicated study in a specific population, and a 2025 meta-analysis found NMN and NR do not reliably improve muscle strength or mass. Treat it as promising, not proven.
What dose of NMN did the endurance study use?
The runners trial tested roughly 300 to 1200 mg/day across low, middle, and high groups for six weeks. The benefit was dose-dependent: the middle and high doses (around 600 and 1200 mg/day) drove the aerobic-capacity improvement, while the lowest dose did not clearly separate from placebo.
Will NMN raise my VO₂ max?
The 48-runner trial did not show a VO₂ max benefit. It found changes in submaximal ventilatory-threshold measures, which are different from maximal oxygen uptake or actual race performance. A higher threshold does not prove NMN improves every endurance outcome.
Is NMN a pre-workout that gives energy before training?
No. NMN is not a stimulant and won't give an acute pre-workout lift. Any plausible benefit is a slow, adaptation-level effect from chronic dosing, which is exactly why its real-world impact is easy to overestimate. Training, protein, sleep, and iron status move endurance far more reliably.
References
- Yi L, Maier AB, Tao R, et al. (2023). The efficacy and safety of beta-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial. GeroScience. https://pubmed.ncbi.nlm.nih.gov/36482258/
- Pencina KM, Lavu S, Dos Santos M, et al. (2023). MIB-626, an Oral Formulation of a Microcrystalline Unique Polymorph of beta-Nicotinamide Mononucleotide, Increases Circulating Nicotinamide Adenine Dinucleotide and its Metabolome in Middle-Aged and Older Adults. The Journals of Gerontology: Series A. https://pubmed.ncbi.nlm.nih.gov/35182418/
- Liao B, Zhao Y, Wang D, Zhang X, et al. (2021). Nicotinamide mononucleotide supplementation enhances aerobic capacity in amateur runners: a randomized, double-blind study. Journal of the International Society of Sports Nutrition. https://pubmed.ncbi.nlm.nih.gov/34238308/
- Prokopidis K, Moriarty F, Bahat G, et al. (2025). The Effect of Nicotinamide Mononucleotide and Riboside on Skeletal Muscle Mass and Function: A Systematic Review and Meta-Analysis. Journal of Cachexia, Sarcopenia and Muscle. https://pubmed.ncbi.nlm.nih.gov/40275690/
- Elhassan YS, Lavery GG, et al. (2019). Nicotinamide Riboside Augments the Aged Human Skeletal Muscle NAD+ Metabolome and Induces Transcriptomic and Anti-inflammatory Signatures. Cell Reports. https://pubmed.ncbi.nlm.nih.gov/31412242/
- Campelj D, Philp A (2022). NAD+ Therapeutics and Skeletal Muscle Adaptation to Exercise in Humans. Sports Medicine. https://pubmed.ncbi.nlm.nih.gov/36331703/
- Akasaka H, Nakagami H, Sugimoto K, et al. (2023). Effects of nicotinamide mononucleotide on older patients with diabetes and impaired physical performance: A prospective, placebo-controlled, double-blind study. Geriatrics & Gerontology International. https://pubmed.ncbi.nlm.nih.gov/36443648/
- Yang DL, Chao KC, Yang HT, et al. (2026). Anti-inflammatory effects of nicotinamide mononucleotide (NMN) in human skeletal muscle after BFR-exercise. Journal of the International Society of Sports Nutrition. https://pubmed.ncbi.nlm.nih.gov/41705654/
Medical disclaimer: This content is for general educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before starting, stopping, or changing any treatment.
Related reading
NMN for Sleep & Insomnia: What the Evidence Shows
NMN sleep evidence is small and mixed. The timing trial used evening doses without establishing a sleep-quality advantage; another trial found a modest signal.
ReadNMN for Menopause & Perimenopause: What the Evidence Shows
NMN has a metabolic trial in postmenopausal women, but it does not establish symptom relief. Sleep studies also do not prove a menopause benefit.
ReadBest Time to Take NMN: Morning, Night, or With Food?
No optimal time to take NMN is established. A trial compared morning with evening, but placebo improvements limit claims of a sleep benefit.
ReadNAD+ for Men: Energy, Muscle and Testosterone Evidence
What NAD+ precursor trials in older men show about muscle and function—and why testosterone, ED and fertility claims need different evidence.
ReadWhat Is a NAD+ Injection? The Definition, and the Evidence
NAD+ shots are sold for energy and aging without established wellness benefits. Compare home injection evidence, costs and the separate hearing-loss trial.
ReadNAD+ for Long COVID and ME/CFS: What the Evidence Shows
A 58-person NR trial raised NAD+ without improving long COVID symptoms over placebo. Compare that result with the NAD+ patch pilot and ME/CFS studies.
Read